Join us for our upcoming live webinar on Tuesday, September 22, 2026, where Nils Schomann, QC Manager Method Development, will explore the..
August 25, 2026
From the Lab to the Big Screen: siRNA Enters the Spider-Man Universe
What happens when cutting-edge RNA science meets Hollywood? Apparently, you get Spider-Man discussing siRNA with Bruce Banner.
In Spider-Man: Brand..
August 11, 2026
How Do siRNA Therapies Silence Genes?
RNA interference, or RNAi, is a natural cellular mechanism that helps regulate gene expression. Small interfering RNA, or siRNA, therapies use this..
July 28, 2026
From Bench to Bedside: The Journey of an Oligonucleotide Therapeutic
Every medicine has a story. For nucleic acid therapeutics, drugs based on DNA or RNA molecules, the journey is both complex and inspiring. Starting..
July 14, 2026
Laura Steinhauer & Nils Schomann (Quality Managers Analytical Method Development)
It's the people behind BioSpring who make the difference. Every team member brings unique experiences, skills, and perspectives that strengthen our..
June 30, 2026
Free Webinar: Mastering Manufacturing Challenges in Oligonucleotide Production
Free Webinar: This expert presentation addresses key manufacturing challenges in therapeutic oligonucleotide production as programs scale toward..
June 16, 2026
Dr. Jérôme Mordel, Regulatory Affairs Manager
What sets BioSpring apart is its people. Each team member contributes unique perspectives, experiences, and expertise, creating the foundation for..
June 2, 2026
Process Development for Oligonucleotide Manufacturing
Great results don't happen by chance—they're built on the right expertise. Let's take a closer look at one of the services that helps our customers..
May 19, 2026
Dr. Karin Zweig (Head of Process Development) and Dr. Florian Schäfer (Team Lead Process Development)
Every team member brings something unique to BioSpring. From diverse backgrounds and experiences to individual passions and expertise, it's the..
May 5, 2026
What Makes an Oligonucleotide Therapeutic Different from Traditional Drugs?
A unique characteristic of oligonucleotide-based drugs is that they can act on the root-cause of diseases, instead of treating just symptoms...